IRVING, Texas, July 8, 2008 (PRIME NEWSWIRE) -- DelSite, Inc. (OTC:CARN) officially became the name of Carrington Laboratories, Inc. on June 30, 2008. The name change was approved by the company's shareholders at its annual meeting held on June 26, 2008.
"Changing the name of the company to 'DelSite, Inc.' aligns our corporate identity with the shift in our long-term strategic focus solely to the development and promotion of DelSite's three platform technologies for the delivery of proteins and peptides and development of our typhoid vaccine program. The Costa Rica operations, which support DelSite's programs, will be a key part of DelSite, Inc.," said Carlton E. Turner, Chief Executive Officer of DelSite, Inc. "We believe this change in corporate identity will properly position the Company around our core business and enhance shareholder value."
Shares of the Company's stock will continue trading under the symbol CARN.OB until the Company receives a new trading symbol from the OTCBB. Information related to the new symbol will be disseminated when received.
About DelSite
DelSite, Inc. is an ISO 9001-certified, research-based, biopharmaceutical company currently utilizing naturally-occurring complex carbohydrates technology at its DelSite Biotechnologies subsidiary to develop its proprietary GelSite(r) technology designed for controlled release of peptide and protein-based drugs. DelSite's technology is protected by more than 130 patents in 26 countries. Manufacturing operations comply with cGMP standards. For more information on DelSite's platform technologies visit www.delsite.com.
Certain statements in this release concerning DelSite may be forward-looking. Actual events will be dependent upon a number of factors and risks including but not limited to: subsequent changes in plans by the Company's management; delays or problems in formulation, manufacturing, distribution, production and/or launch of new finished products; changes in the regulatory process; changes in market trends; and a number of other factors and risks described from time to time in the Company's filings with the Securities & Exchange Commission, including the Form 10-Q filed May 15, 2008.